Status:
COMPLETED
Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin
Lead Sponsor:
Royan Institute
Conditions:
Vitiligo
Eligibility:
All Genders
12-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to investigate the efficacy and safety of autologous transplantation of melanocytes in patients with vitiligo.
Detailed Description
Vitiligo is a pigmentation disorder in which white patches of skin appear on different parts of the body. Histologically it is characterized by absence of melanocytes along the epidermal basal layer. ...
Eligibility Criteria
Inclusion
- Age over 12 years
- Stable form of vitiligo (no increase in the size of the lesion for at least one year)
- No use of immunosuppressive \& cytotoxic drugs at least for past 6 months
Exclusion
- Pregnant patients
- Patients with active disease
- Infection at the recipient site
- Evidence of köebner in the past
- Keloidal tendencies
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00631865
Start Date
February 1 2009
End Date
May 1 2015
Last Update
July 20 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royan Institute
Tehran, Tehran Province, Iran, 1665659911